Affordable Access

Publisher Website

Adjunctive virtual reality pain relief after traumatic injury: a proof-of-concept within-person randomized trial.

Authors
  • Morris, Nicholas A1, 2
  • Wang, Yang3
  • Felix, Ryan B1, 2
  • Rao, Aniruddha1, 3
  • Arnold, Shannon1, 2
  • Khalid, Mazhar1
  • Armahizer, Michael J4
  • Murthi, Sarah B2, 5
  • Colloca, Luana3
  • 1 Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, United States. , (United States)
  • 2 Program in Trauma, R Adams Cowley Shock Trauma Center, Baltimore, MD, United States. , (United States)
  • 3 Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, MD, United States. , (United States)
  • 4 Department of Pharmacy, University of Maryland Medical Center, Baltimore, MD, United States. , (United States)
  • 5 Departments of Surgery, University of Maryland School of Medicine, Baltimore, MD, United States. , (United States)
Type
Published Article
Journal
Pain
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Sep 01, 2023
Volume
164
Issue
9
Pages
2122–2129
Identifiers
DOI: 10.1097/j.pain.0000000000002914
PMID: 37079851
Source
Medline
Language
English
License
Unknown

Abstract

In this study, we hypothesized that immersive virtual reality (VR) environments may reduce pain in patients with acute traumatic injuries, including traumatic brain injuries. We performed a randomized within-subject study in patients hospitalized with acute traumatic injuries, including traumatic brain injury with moderate pain (numeric pain score ≥3 of 10). We compared 3 conditions: (1) an immersive VR environment (VR Blu), (2) a content control with the identical environment delivered through nonimmersive tablet computer (Tablet Blu), and (3) a second control composed of donning VR headgear without content to control for placebo effects and sensory deprivation (VR Blank). We enrolled 60 patients, and 48 patients completed all 3 conditions. Objective and subjective data were analyzed using linear mixed-effects models. Controlling for demographics, baseline pain, and injury severity, we found differences by conditions in relieving pain (F 2,75.43 = 3.32, P = 0.042). VR Blu pain reduction was greater than Tablet Blu (-0.92 vs -0.16, P = 0.043), but VR Blu pain reduction was similar to VR Blank (-0.92 vs -1.24, P = 0.241). VR Blu was perceived as most effective by patients for pain reduction (F 2,66.84 = 16.28, P < 0.001), and changes in measures of parasympathetic activity including heart rate variability (F 2,55.511 = 7.87, P < 0.001) and pupillary maximum constriction velocity (F 2,61.41 = 3.50, 1-tailed P = 0.038) echoed these effects. There were no effects on opioid usage. These findings outlined a potential clinical benefit for mollifying pain related to traumatic injuries. Copyright © 2023 International Association for the Study of Pain.

Report this publication

Statistics

Seen <100 times